Stock Track | Argenx SE Plunges 12.80% Pre-Market Despite Beating EPS Estimates, Operating Income Falls Short

Stock Track

May 08, 2025

Shares of Argenx SE (ARGX) tumbled 12.80% in pre-market trading on Thursday, despite the company reporting better-than-expected first-quarter earnings. The biotechnology firm's stock price reaction highlights investors' concerns over its operating performance, which fell short of analyst projections.

Argenx reported Q1 earnings of $2.58 per diluted share, surpassing the FactSet analyst consensus of $2.41 and marking a significant turnaround from the $1.04 loss per share in the same quarter last year. However, the company's operating income for the quarter ended March 31 came in at $807.4 million, falling short of the $817.6 million expected by analysts surveyed by FactSet.

Adding to investor uncertainty, Argenx maintained its financial guidance for the fiscal year 2025, targeting combined selling, general and administrative (SG&A) and research and development (R&D) expenses of approximately $2.5 billion. The unchanged guidance, coupled with the lower-than-expected operating income, appears to have overshadowed the positive EPS surprise, leading to the sharp pre-market decline in Argenx's stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1149693976"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149693976\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149693976?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-08 17:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149693976","market":"hk","top_or_hot":-1,"title":"Stock Track | Argenx SE Plunges 12.80% Pre-Market Despite Beating EPS Estimates, Operating Income Falls Short","media":"Stock Track","content":"<p>Shares of Argenx SE (ARGX) tumbled 12.80% in pre-market trading on Thursday, despite the company reporting better-than-expected first-quarter earnings. The biotechnology firm's stock price reaction highlights investors' concerns over its operating performance, which fell short of analyst projections.</p>\n\n<p>Argenx reported Q1 earnings of $2.58 per diluted share, surpassing the FactSet analyst consensus of $2.41 and marking a significant turnaround from the $1.04 loss per share in the same quarter last year. However, the company's operating income for the quarter ended March 31 came in at $807.4 million, falling short of the $817.6 million expected by analysts surveyed by FactSet.</p>\n\n<p>Adding to investor uncertainty, Argenx maintained its financial guidance for the fiscal year 2025, targeting combined selling, general and administrative (SG&A) and research and development (R&D) expenses of approximately $2.5 billion. The unchanged guidance, coupled with the lower-than-expected operating income, appears to have overshadowed the positive EPS surprise, leading to the sharp pre-market decline in Argenx's stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Argenx SE Plunges 12.80% Pre-Market Despite Beating EPS Estimates, Operating Income Falls Short</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Argenx SE Plunges 12.80% Pre-Market Despite Beating EPS Estimates, Operating Income Falls Short\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-08 17:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Argenx SE (ARGX) tumbled 12.80% in pre-market trading on Thursday, despite the company reporting better-than-expected first-quarter earnings. The biotechnology firm's stock price reaction highlights investors' concerns over its operating performance, which fell short of analyst projections.</p>\n\n<p>Argenx reported Q1 earnings of $2.58 per diluted share, surpassing the FactSet analyst consensus of $2.41 and marking a significant turnaround from the $1.04 loss per share in the same quarter last year. However, the company's operating income for the quarter ended March 31 came in at $807.4 million, falling short of the $817.6 million expected by analysts surveyed by FactSet.</p>\n\n<p>Adding to investor uncertainty, Argenx maintained its financial guidance for the fiscal year 2025, targeting combined selling, general and administrative (SG&A) and research and development (R&D) expenses of approximately $2.5 billion. The unchanged guidance, coupled with the lower-than-expected operating income, appears to have overshadowed the positive EPS surprise, leading to the sharp pre-market decline in Argenx's stock price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARGX","symbol_name":"Argenx SE","start_time":0,"source_url":"","article_id":"1149693976","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149693976","pubTimestamp":1746698212,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Argenx SE  tumbled 12.80% in pre-market trading on Thursday, despite the company reporting better-than-expected first-quarter earnings. The biotechnology firm's stock price reaction highlights investors' concerns over its operating performance, which fell short of analyst projections.Argenx reported Q1 earnings of $2.58 per diluted share, surpassing the FactSet analyst consensus of $2.41 and marking a significant turnaround from the $1.04 loss per share in the same quarter last year. H","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARGX":"Argenx SE"},"translate_title":"尽管每股收益超出预期，但营业收入未达预期，Argenx SE盘前暴跌12.80%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARGX":1},"content_text":"Shares of Argenx SE (ARGX) tumbled 12.80% in pre-market trading on Thursday, despite the company reporting better-than-expected first-quarter earnings. The biotechnology firm's stock price reaction highlights investors' concerns over its operating performance, which fell short of analyst projections.\nArgenx reported Q1 earnings of $2.58 per diluted share, surpassing the FactSet analyst consensus of $2.41 and marking a significant turnaround from the $1.04 loss per share in the same quarter last year. However, the company's operating income for the quarter ended March 31 came in at $807.4 million, falling short of the $817.6 million expected by analysts surveyed by FactSet.\nAdding to investor uncertainty, Argenx maintained its financial guidance for the fiscal year 2025, targeting combined selling, general and administrative (SG&A) and research and development (R&D) expenses of approximately $2.5 billion. The unchanged guidance, coupled with the lower-than-expected operating income, appears to have overshadowed the positive EPS surprise, leading to the sharp pre-market decline in Argenx's stock price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}